ATLANTA, GA (December 21, 2010) - Thawer Ashcroft Crowne & Co. announced today that it has Launched a private special purpose acquisition company, Life Ventures Series I with a $250M collateralized investment security, where the shareholders’ interest is secured with a default-proof, collateral- backed portfolio of funded assets with face values equal to or exceeding the total amount invested in Life Ventures Series I. Life Ventures Series I will be acquiring limited interests in healthcare startup companies with investments ranging from $1M to $4M per venture.
Rahim Thawer, Thawer Ashcroft Crowne & Company’s Managing Member said “We are delighted in enhancing human lives through our partnerships and alliances with flexible capital into outstanding ventures through conceptualization, innovation and implementation. It is Thawer Ashcroft Crowne & Co’s initiative to support innovation in the healthcare related ventures for the betterment of the human race and introduce new concepts and ideas. This partnership will yield strong capital structures for all the parties involved and further enhance its unprecedented and innovative models.” Life Ventures Series I will invest in startup companies that are in healthcare, medical, pharmaceuticals, biotechnology, etc as early as January 2011.
Thawer Ashcroft Crowne & Co.’s innovative and intricate financial investment models play an influential part in acquiring capital for various industries through its nonconventional yet solid strategies, which entail offering an investment security via full collateralization of distinct asset classes. Thawer Ashcroft Crowne & Co is a pioneer in offering such security to all parties engaged, yielding favorable results.
Thawer Ashcroft Crown & Co. Contact:
Sara Thawer, Public Relations
pr@thawerco.com
